The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiomic spatial analysis of tumor microenvironment during neuroendocrine (NE) transformation in EGFR-mutant LUAD.
 
Elisa Gobbini
Employment - AstraZeneca (I)
Research Funding - AstraZeneca (Inst); SERVIER
Travel, Accommodations, Expenses - Bristol Myers Squibb; Johnson & Johnson/Janssen; Takeda
 
Darwin D'souza
No Relationships to Disclose
 
Emir Radkevich
No Relationships to Disclose
 
Subhamoy Chakraborty
No Relationships to Disclose
 
Bi Chongfeng
No Relationships to Disclose
 
Chih-wei Fan
No Relationships to Disclose
 
Raina Roche
No Relationships to Disclose
 
Felix Carl Saalfeld
No Relationships to Disclose
 
Deniz Demircioglu
No Relationships to Disclose
 
Seunghee Kim-Schulze
No Relationships to Disclose
 
Dan Hasson
No Relationships to Disclose
 
Zhihong Chen
No Relationships to Disclose
 
Martin Wermke
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; GWT; Janssen; Lilly; Merck Serono; MJH/PER; Novartis; Pfizer; Regeneron; SYNLAB; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Genentech; ImCheck therapeutics; immatics; Iovance Biotherapeutics; ISA Pharmaceuticals; Lilly; Novartis; PharmaMar; Regeneron; Roche; T-Knife; Tacalyx; Zymeworks
Research Funding - Boehringer Ingelheim (Inst); Iovance Biotherapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GEMoaB; immatics; Iovance Biotherapeutics; Janssen Oncology; Merck Serono; Pfizer; Sanofi/Aventis
 
Triparna Sen
Research Funding - Debiopharm Group; Jazz Pharmaceuticals